Symbiomix Therapeutics, LLC logo

Symbiomix Therapeutics, LLC Employee Directory

PharmaceuticalsNew Jersey, United States2-10 Employees

Symbiomix Therapeutics, LLC is a biopharmaceutical company focused on developing medicines to treat prevalent gynecological infections that can have serious health consequences. The Newark, New Jersey-based company, founded in 2012, operates additional offices in Maryland and Connecticut and belongs to the pharmaceutical manufacturing sector. 

One of its products, Solosec (secnidazole oral granules), is intended for the treatment of bacterial vaginosis, and the company filed a new drug application with the U.S. Food and Drug Administration in January 2017. In February 2017, David L. Stern was appointed as CEO. The organization remains a relatively small enterprise focusing on developing therapies for gynecological infections and related health outcomes.

Find Symbiomix Therapeutics, LLC employees' phone numbers or email addresses

Symbiomix Therapeutics, LLC Global Highlights

Location
Employees

North America
7

Minus sign iconPlus sign icon
  • United States Of America
    7

Symbiomix Therapeutics, LLC's Leadership

  • Stylized image of a person
    D. S.
    Chief Executive Officer
  • Stylized image of a person
    C. B.
    Chief Medical Officer
  • Stylized image of a person
    N. A.
    Vice President Clinical Operations And Project Ma
  • Stylized image of a person
    S. R.
    Vice President Regulatory Affairs And Quality
  • Stylized image of a person
    R. J.
    President And Chief Financial Officer
  • Stylized image of a person
    T. B.
    Head Of Research And Development Chief Medical Officer

Contact profiles from Symbiomix Therapeutics, LLC

Name
Title
Contact
Location
Last Update
  • Stylized image of a person
    C. B.
    Chief Medical Officer
    Oct 18, 2024
  • Stylized image of a person
    D. S.
    Chief Executive Officer
    Oct 23, 2024
  • Stylized image of a person
    R. J.
    President And Chief Financial Officer
    Oct 17, 2024
  • Stylized image of a person
    T. B.
    Head Of Research And Development Chief Medical Officer
    Oct 17, 2024
  • Stylized image of a person
    N. A.
    Vice President Clinical Operations And Project Ma
    Oct 23, 2024
  • Stylized image of a person
    S. R.
    Vice President Regulatory Affairs And Quality
    Oct 18, 2024

Frequently Asked Questions

What is Symbiomix Therapeutics, LLC known for?

Minus sign iconPlus sign icon
Symbiomix Therapeutics, LLC operates in the Pharmaceuticals industry; you can contact the main corporate office by phone at . Explore Symbiomix Therapeutics, LLC's company overview page for more information.

What is Symbiomix Therapeutics, LLC's most common email format?

Minus sign iconPlus sign icon
Symbiomix Therapeutics, LLC employees' email format typically follows the pattern of . Trying to find reliable and up-to-date employee contact data? Find more Symbiomix Therapeutics, LLC email formats with LeadIQ.

How many employees does Symbiomix Therapeutics, LLC have currently?

Minus sign iconPlus sign icon
Symbiomix Therapeutics, LLC has approximately 7 employees as of July 2026. These team members are located across 1 continents, including North America.

Who are Symbiomix Therapeutics, LLC's key employees and leadership?

Minus sign iconPlus sign icon

As of July 2026, Symbiomix Therapeutics, LLC's key employees include:

  • Chief Executive Officer: D. S.
  • Chief Medical Officer: C. B.
  • Vice President Clinical Operations And Project Ma: N. A.
  • Vice President Regulatory Affairs And Quality: S. R.
  • President And Chief Financial Officer: R. J.

Looking for contact data? Unlock accurate emails and phone numbers for your ideal prospects with LeadIQ.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.